These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 30912053)
1. Toward In Vivo Gene Therapy Using CRISPR. Skipper KA; Mikkelsen JG Methods Mol Biol; 2019; 1961():293-306. PubMed ID: 30912053 [TBL] [Abstract][Full Text] [Related]
2. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1. Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139 [TBL] [Abstract][Full Text] [Related]
3. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199 [TBL] [Abstract][Full Text] [Related]
4. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption. Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809 [TBL] [Abstract][Full Text] [Related]
5. Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review. Long C; Amoasii L; Bassel-Duby R; Olson EN JAMA Neurol; 2016 Nov; 73(11):1349-1355. PubMed ID: 27668807 [TBL] [Abstract][Full Text] [Related]
6. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina. Yu W; Wu Z Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971 [TBL] [Abstract][Full Text] [Related]
7. Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing. Min YL; Chemello F; Li H; Rodriguez-Caycedo C; Sanchez-Ortiz E; Mireault AA; McAnally JR; Shelton JM; Zhang Y; Bassel-Duby R; Olson EN Mol Ther; 2020 Sep; 28(9):2044-2055. PubMed ID: 32892813 [TBL] [Abstract][Full Text] [Related]
8. Viral Delivery of Compact CRISPR-Cas12f for Gene Editing Applications. Sharrar A; Meacham Z; Staples-Ager J; Arake de Tacca L; Rabuka D; Collingwood T; Schelle M CRISPR J; 2024 Jun; 7(3):150-155. PubMed ID: 38695159 [TBL] [Abstract][Full Text] [Related]
9. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9. Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718 [TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9 in genome editing: Its function and medical applications. Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544 [TBL] [Abstract][Full Text] [Related]
11. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models. Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764 [TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9 DNA Base-Editing and Prime-Editing. Kantor A; McClements ME; MacLaren RE Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872311 [TBL] [Abstract][Full Text] [Related]
19. CRISPR: development of a technology and its applications. Derry WB FEBS J; 2021 Jan; 288(2):358-359. PubMed ID: 33300275 [TBL] [Abstract][Full Text] [Related]
20. Rapid and Simple Screening of CRISPR Guide RNAs (gRNAs) in Cultured Cells Using Adeno-Associated Viral (AAV) Vectors. Fakhiri J; Nickl M; Grimm D Methods Mol Biol; 2019; 1961():111-126. PubMed ID: 30912043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]